Funding for this research was provided by:
Canadian Institutes of Health Research (MOP69005)
Merck Sharp and Dohme
Article History
Received: 28 October 2019
Accepted: 10 February 2020
First Online: 3 March 2020
Ethics approval and consent to participate
: This study was approved by the research ethics committee of the CIUSSS de l’Estrie - CHUS (#2016–1197) and the consent of all participants was obtained via a reverse consent form. Each potential participant was sent a letter detailing the experiments and asked to return the form if they wished to opt-out of the microbiome studies. Absence of response was considered as consent to participate and this consent can be revoked at any time during the study.
: Not applicable.
: The authors declare that they have no competing interests.